Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
SHED logo

SHED Weight Loss Reviews

Get 30% off your first month

Last updated: Sep 14, 2026

8.7/10Very Good - our rating

Medically reviewed on

How we review

Visit SHED

We may earn a commission from links on this page - it never affects our rankings (how we stay objective).

The bottom line

SHED is the coaching-and-accountability pick among our affiliate providers, with health coaching included in every plan rather than sold as an upsell. The 5%-in-120-days money-back guarantee is the most concrete promise in our ranking and takes real risk off the table.

What you're weighing is price: at $199-$299/month it costs two to three times the entry tier at welludr or embody, and if you'd skip the coaching calls anyway, that premium buys you little. If you want medication plus real support with a safety net, SHED delivers; if you just want the cheapest possible GLP-1 access, look down-market first.

SHED is a telehealth weight-loss program with 150,000+ members, built around compounded GLP-1 medication - semaglutide from $199/month and tirzepatide from $299/month, both with 20% off the first month - paired with health coaching that's included in every plan rather than sold as an upsell. The whole flow is 100% online: complete a visit, and if approved your medication ships straight to your door.

Plans are HSA/FSA approved, and SHED backs the program with the most concrete guarantee in our ranking: lose 5% of your body weight in 120 days or your money back. The honest catch is price: $199-$299/month is the highest compounded tier among our affiliate providers, so you're paying for the coaching and the guarantee, not just the medication.

Key Features

  • Compounded semaglutide from $199/mo, tirzepatide from $299/mo
  • 20% off your first month
  • Health coaching included in every plan
  • Lose 5% of your body weight in 120 days or your money back
  • HSA/FSA approved; 150,000+ members

Treatment Options

  • Compounded semaglutide (GLP-1) injection
  • Compounded tirzepatide (GLP-1 + GIP) injection
  • Health coaching included with every plan
  • Progress tracking and check-ins

Pricing

Compounded Semaglutide

Weekly

GLP-1 injection

$199/month
  • 20% off your first month
  • Health coaching & shipping included

Compounded Tirzepatide

Weekly

GLP-1 + GIP injection

$299/month
  • 20% off your first month
  • Dual-action GLP-1 + GIP formulation

SHED keeps pricing simple: compounded semaglutide starts at $199/month and compounded tirzepatide starts at $299/month, with 20% off your first month. Every plan includes the provider visit, health coaching, and medication shipped straight to your door - and it's HSA/FSA approved.

SHED also backs it with a guarantee: lose 5% of your body weight in 120 days or your money back.

What we verified

Checked September 2026

Every line below was checked against SHED's own published pricing and plan information - not copied from other review sites. When we can't verify something, we leave it out rather than guess.

Semaglutide price
$199/month
Tirzepatide price
$299/month
Guarantee
5% of body weight in 120 days or your money back
Payment options
HSA/FSA eligible

Pros

  • Health coaching included in every plan, not an add-on
  • Real money-back guarantee: lose 5% in 120 days or your money back
  • 20% off the first month; HSA/FSA approved
  • 100% online visit and checkout with home delivery

Cons

  • Highest compounded pricing in our ranking - $199/mo semaglutide vs $41-$147 elsewhere
  • The money-back guarantee has conditions (5% in 120 days - check current terms)
  • Compounded only - no brand-name Ozempic/Wegovy/Zepbound shelf

Interested in SHED?

Visit their site to check eligibility and current pricing.

Visit SHED

Who It's Best For

  • People who want structured coaching alongside GLP-1 medication
  • Anyone who wants a concrete money-back guarantee behind the program
  • Those who plan to pay with HSA/FSA funds

Final Verdict

SHED is the coaching-and-accountability pick among our affiliate providers, with health coaching included in every plan rather than sold as an upsell. The 5%-in-120-days money-back guarantee is the most concrete promise in our ranking and takes real risk off the table.

What you're weighing is price: at $199-$299/month it costs two to three times the entry tier at welludr or embody, and if you'd skip the coaching calls anyway, that premium buys you little. If you want medication plus real support with a safety net, SHED delivers; if you just want the cheapest possible GLP-1 access, look down-market first.

Visit SHED

SHED Review: FAQs

Is SHED legit?

SHED is a telehealth weight-loss program with 150,000+ members, built around compounded GLP-1 medication - semaglutide from $199/month and tirzepatide from $299/month, both with 20% off the first month - paired with health coaching that's included in every plan rather than sold as an upsell. The whole flow is 100% online: complete a visit, and if approved your medication ships straight to your door. Plans are HSA/FSA approved, and SHED backs the program with the most concrete guarantee in our ranking: lose 5% of your body weight in 120 days or your money back. The honest catch is price: $199-$299/month is the highest compounded tier among our affiliate providers, so you're paying for the coaching and the guarantee, not just the medication.

How much does SHED cost?

SHED keeps pricing simple: compounded semaglutide starts at $199/month and compounded tirzepatide starts at $299/month, with 20% off your first month. Every plan includes the provider visit, health coaching, and medication shipped straight to your door - and it's HSA/FSA approved. SHED also backs it with a guarantee: lose 5% of your body weight in 120 days or your money back.

What treatments does SHED offer?

SHED offers Compounded semaglutide (GLP-1) injection, Compounded tirzepatide (GLP-1 + GIP) injection, Health coaching included with every plan, Progress tracking and check-ins.

Who is SHED best for?

SHED is best for People who want structured coaching alongside GLP-1 medication; Anyone who wants a concrete money-back guarantee behind the program; Those who plan to pay with HSA/FSA funds.

Is SHED worth it?

SHED is the coaching-and-accountability pick among our affiliate providers, with health coaching included in every plan rather than sold as an upsell. The 5%-in-120-days money-back guarantee is the most concrete promise in our ranking and takes real risk off the table. What you're weighing is price: at $199-$299/month it costs two to three times the entry tier at welludr or embody, and if you'd skip the coaching calls anyway, that premium buys you little. If you want medication plus real support with a safety net, SHED delivers; if you just want the cheapest possible GLP-1 access, look down-market first.

What is SHED's money-back guarantee?

SHED promises that if you lose less than 5% of your body weight in 120 days on the program, you get your money back - the most concrete guarantee among the providers we rank. Check SHED's site for the current terms and conditions.

Does SHED include coaching?

Yes - health coaching is included in every plan rather than sold as an add-on, alongside the provider visit and home delivery.

Can I pay for SHED with HSA/FSA funds?

Yes - SHED plans are HSA/FSA approved. Compounded semaglutide starts at $199/month and tirzepatide at $299/month, with 20% off your first month.

Not sure if SHED is right for you?

Take our free quiz and get a personalized provider recommendation.

Find Your Match

More on SHED

The questions people ask before signing up - answered in depth.

Sources & methodology

We built this review of SHED from the provider'sown published pricing, plans and policies, cross-checked against regulatory and peer-reviewed medical references, and read alongside real customer feedback. Prices and plan details were verified against the provider's published information; we do not take providers' word for their own claims without checking.

Provider information

Pricing, plans, shipping and policies, checked against each provider's own site.

  • SHED - pricing, plans & policies as published on its own site

Provider data checked September 2026

Customer & community feedback

Third-party signals shown on this page and in our full reviews: public Reddit discussions and independent YouTube reviews. We report what these sources say - we never fold them into our own scores.

Medical & regulatory references

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)

Last reviewed September 2026. We revisit comparisons when providers change their pricing or policies. This page is information only and is not medical advice - always consult a licensed clinician before starting treatment.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)